Welcome To Medicare: Pfizer Sees Part D As Key To Rebirth
Executive Summary
The Medicare prescription drug benefit will be a key factor for energizing Pfizer's growth, CEO Hank McKinnell indicated during the Morgan Stanley Pharmaceutical CEOs Unplugged conference in New York Jan. 4
You may also be interested in...
Sanofi Tries To Quash Bristol Rumors; M&A Efforts Center On Biotech, Japan
Sanofi-Aventis' merger and acquisition efforts will focus on biotech firms and Japanese companies, CEO Gerard Le Fur maintained Feb. 13
Sanofi Tries To Quash Bristol Rumors; M&A Efforts Center On Biotech, Japan
Sanofi-Aventis' merger and acquisition efforts will focus on biotech firms and Japanese companies, CEO Gerard Le Fur maintained Feb. 13
Sanofi Tries To Quash Bristol Rumors; M&A Efforts Center On Biotech, Japan
Sanofi-Aventis' merger and acquisition efforts will focus on biotech firms and Japanese companies, CEO Gerard Le Fur maintained Feb. 13